| Entry |
|
|---|
| Name |
Cixutumumab (USAN) |
|---|
| Formula |
C6500H10052N1724O2036S44
|
|---|
| Exact mass |
146244.3741
|
|---|
| Mol weight |
146334.63
|
|---|
| Efficacy |
Antineoplastic, Insulin-like growth factor 1 receptor antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of solid tumors
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
IGF1R (CD221)
D09328 Cixutumumab (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
